Frederick biotech Veralox Therapeutics raises $5.4 million seed round
Source: External source
Frederick biotechnology firm Veralox Therapeutics has raised a $5.4 million seed round of funding, to help push its first drug candidate toward clinical trials.
Posted September 5, 2019
About TEDCO
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com.
Media Contacts
Tammi Thomas, President, TEDCO, tthomas@tedcomd.com
Rachael Kalinyak, Associate Director, Marketing & Communications, TEDCO, rkalinyak@tedcomd.com